About Us

Your Name

Jeff Twidwell, MD

Chairman of the Board of Governors, Founder

Dr. Jeffry Twidwell is a board certified urologist with over 20 years of clinical experience. He has been involved in numerous scientific studies and publications. He is a well-regarded urologist in the Minneapolis, Minnesota area and has been named annually to the “top doctors” list in MPLS-St. Paul Magazine since 1997. He is a graduate of Creighton University Medical School and did his urology training at the Naval Hospital in San Diego, California.

Your Name

Harold Hoium, MBA

President & CEO, Board of Governors

Mr. Hoium has been in the medical industry for approximately 30 years. He has specific expertise and experience in corporate finance, FDA efforts, international clinical trials, product development, manufacturing, CE mark, marketing and overall corporate strategy. He has served as President and co-founder of Harbinger Medical since 1992. Mr. Hoium has held several management positions at Dimensional Medicine (1983-1992), including Vice President OEM Programs and Vice President Workstation Operations. Mr. Hoium has held positions at Perkin Elmer Corporation (1979-1983), Control Data Corporation (1976-1979), and Honeywell (1973-1976). He holds an MBA from the University of Minnesota (1991), and BA in Mathematics (1972) and Computer Science (1973) from Moorhead State University. Mr. Hoium holds 14 US and international patents and is an author of numerous medical publications.

Laurence A. Levine, MD, FACS

Chief Medical Advisor

Professor of Urology, Rush University, Chicago, Illinois. Dr. Levine has made a substantial contribution to the medical press in the form of peer- reviewed articles, abstracts, book chapters, and Internet publications regarding Peyronie’s disease, male sexual dysfunction, fertility, chronic orchialgia and reconstructive urology. He is an ad hoc reviewer for The Journal of Urology, Urology, Journal of Sexual Medicine, Journal of Andrology, Asian Journal of Andrology, British Journal of Urology, European Journal of Urology and International Brazilian Journal of Urology.

Dr. Levine is the editor and contributor to the first textbook on Peyronie’s disease published by Humana Press in December 2006 and a patient guide entitled “Understanding Peyronie’s disease” published by Addicus Books in 2007. He also has an active involvement in basic science research on Peyronie’s disease at Rush University Medical Center where he and his colleagues are looking for the causes and new treatments for this distressing medical problem.

Dan Moudry, RPh

Moudry RX-Compounding Pharmacy

Dr. Moudry is the founder of Moudry RX and will assist Hybrid Medical as needed in pharmacy compounding efforts for products going forward. Moudry RX can manufacture the compounds required for initial patient testing and early sales. Moudry Rx-Compounding Pharmacy is a full service compounding pharmacy that works with prescribers and patients to customize prescription medications throughout Minnesota. Moudry’s, a well-recognized and trusted name in pharmacy, has served the Minneapolis and St. Paul metro areas since 1929.

Timothy E. Bianchi, JD

Intellectual Property Counsel, Schwegman, Lundberg, Woessner

Schwegman, Lundberg, Woessner has obtained over 7,000 patents and is focused exclusively on intellectual property. This firm creates value for clients by applying expertise in intellectual property law to obtain, evaluate, and develop patents.

Kermit Nash, JD

Corporate Counsel, Gray Plant Mooty

Mr. Nash serves as corporate counsel to numerous domestic and international companies and funds, advising his clients on all aspects of business operations and law with an emphasis in business law, strategy, mergers & acquisitions and corporate governance.

Pharmacy Consultant and Manufacturing Partner

Dan Moudry, Pharm.D., RPh

Moudry RX-Compounding
1266 Helmo Avenue North
Oakdale, MN 55128

Scientific Advisory Board

Jeff Twidwell, MD, Chairman

The Scientific Advisory Board will be made up of international industry leaders who can help move this technology forward in terms of medical science contribution, clinical trials, publications, conference presentations and medical science strategy. Candidates have been identified and will be added per company needs and conversation with the candidate. They will help guide the new Hybrid Medical product into the market from a physician‘s point of view.